↓ Skip to main content

Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

Overview of attention for article published in BMC Cancer, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
114 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer
Published in
BMC Cancer, August 2019
DOI 10.1186/s12885-019-6054-x
Pubmed ID
Authors

K. M. Islam, T. Anggondowati, P. E. Deviany, J. E. Ryan, A. Fetrick, D. Bagenda, M. S. Copur, A. Tolentino, I. Vaziri, H. A. McKean, S. Dunder, J. E. Gray, C. Huang, A. K. Ganti

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 114 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 114 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 17 15%
Student > Bachelor 12 11%
Student > Ph. D. Student 10 9%
Researcher 5 4%
Other 3 3%
Other 8 7%
Unknown 59 52%
Readers by discipline Count As %
Medicine and Dentistry 12 11%
Nursing and Health Professions 11 10%
Biochemistry, Genetics and Molecular Biology 8 7%
Engineering 6 5%
Agricultural and Biological Sciences 5 4%
Other 13 11%
Unknown 59 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 November 2019.
All research outputs
#4,257,217
of 23,166,665 outputs
Outputs from BMC Cancer
#1,028
of 8,403 outputs
Outputs of similar age
#83,696
of 340,376 outputs
Outputs of similar age from BMC Cancer
#21
of 159 outputs
Altmetric has tracked 23,166,665 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,403 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 340,376 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 159 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.